13
Views
4
CrossRef citations to date
0
Altmetric
Review Papers

Lessons Learnt from Carotid Artery Trials

&
Pages 489-499 | Published online: 11 Mar 2016

References

  • North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade stenosis. N Engl J Med, 1991, 325: 445–453.
  • European Carotid Surgery Trialists’Collaborative Group. Randomized trial of endarterectomy for recently symptomatic carotid stenosis: final results for the MRC European Carotid Surgery Trial (ECST). Lancet, 1998, 351: 1379–87.
  • Rothwell P., Eliasziw M., Gutnickov S. et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet, 2003, 361: 107–116.
  • Mayberg M., Wilson E., Yatsu F. et al. for the Veterans Affairs Cooperative Studies Program 309 Trialist Group. Carotid endarterectomy and ischemia in symptomatic carotid stenosis. JAMA, 1991, 266: 3289–94.
  • Barnett H., Taylor D., Eliasziw M., Fox A., Ferguson G et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy. Trial collaborators. N Engl J Med, 1998, 339: 1415–1425.
  • Naylor A., Rothwell P., Bell P. Overview of the principal results and secondary analyses from the European and North American randomized trials of endarterectomy for symptomatic carotid stenosis. Eur J Vac Endovasc Surg, 2003, 26: 115–129.
  • Featherstone R., Brown M., Coward J., less Investigators. international carotid stenting study: protocol for a randomized clinical trial comparing carotid stenting with endarterectomy in symptomatic carotid artery stenosis. Cerebrovasc Dis, 2004, 18: 69–74.
  • Ringleb P., Kunze A., Allenberg J. et al. Steering comittee of the SPACE Study. The stent supported percutaneous angioplasty of the carotid artery versus endartrerectomy trial. Cerebrovasc Dis, 2004, 18: 66–68.
  • Hobson R., Howard V., Robin G. et al. CREST—investigators. Carotid artery stenting is associated with increased complications in octogenarians: 30 days stroke and death rate in the CREST lead-in phase. J Vasc Surg, 2004, 40: 1106–11.
  • Mas J., Chatelier G., Beyssen B. Carotid angioplasty and stent-ing with and without cerebral protection. Clinical alert from the endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial. Stroke, 2004, 35: 18–21.
  • Van Damme H., Limet R. Analyse des résultats des principales études randomisées d’endartérectomie carotidienne pour sténose asymptomatique. Rev Med Lg, 2005, 60: 811–813.
  • Halm E., Chassin M., Tuhrim S., Hollier L et al. Revisiting appropriateness of carotid endarterectomy. Stroke, 2003, 34: 1464–1472.
  • Executive Comittee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis (AÇAS). JAMA, 1995, 273: 1421–1428.
  • Halliday A., Lansfeld A., Marro D. et al. MRÇ-Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet, 2004, 363: 1491–1502.
  • Cheung B., Lauder I., Kumana C. Meta-analysis of large randomised controlled trials to evaluate the impact of statins on cardiovascular outcomes. Br J Clin Pharmacol, 2004, 57: 64069.
  • Hankey G., Sudlow C., Dunbabin D. Thienopyridine derivates versus ASA for preventing stroke and other serious vascular events in high vascular risk patients. Cochrane Library Update, 2001, issue 1.
  • Yadav J., Wholey M., Kuntz R. et al. Stenting and angioplasty with protection in patients at high risk for endarterectomy (SAPPHIRE) investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med, 2004, 351: 1493–1501.
  • McKinley S., White R., Dietrich E., Fogarty T., Zarins C., Hopkins L. et al. Carotid revascularisation using endarterectomy or stenting systems (CARESS): phase 1 clinical trial. J Endovasc Ther, 2003, 10: 1021–1030.
  • Rothwell P., Eliasziw M., Gutnikow S., Warlow C., Barnett H., for the Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet, 2004, 363: 915924.
  • Ferguson G., Eliasziw M., Barr H., Clagett G., Barnes P., Walace Ç. et al. The NASCET trial: surgical results in 1415 patients. Stroke, 1999, 30: 1751–1758.
  • Bond R., Narayan S., Rothwell P., Warlow C. Clinical and radiographic risk factors for operative stroke and death in the European Carotid Surgery Trial. Eur J Vasc Endovasc Surg, 2002, 23: 108–116.
  • Halm E., Hannan E., Rojas M., Tuhrim S., Riles T., Rockman C., Chassin M. Clinical and operative predictors of outcomes of carotid endarterectomy. J Vasc Surg, 2005, 42: 420–428.
  • Perler B., Dardik A., Burleyson G., Gordon T., Williams G. influence of age and hospital volume on the results of carotid endarterectomy: a statewide analysis of 9918 cases. J Vasc Surg, 1998, 27: 25–31.
  • Stanziale S., Marone L., Boules T., Brimmeier j., Hill K., Makaroun M., Wholey M. Carotid artery stenting in octogenarians is associated with increased adverse outcomes. J Vasc Surg, 2006, 43: 297–304.
  • Van Damme H., Lacroix H., Desiron Q., Nevelsteen A., Limet R., Suy R. Carotid surgery in octogenarians: is it worthwhile ? Acta Chir Belg, 1996, 96: 71–77.
  • Rockman C. Carotid endarterectomy in patients with contralateral carotid occlusion. Sem Vasc Surg, 2004, 17: 224–229.
  • Narins C., Illig K. Patient selection for carotid stenting versus endarterectomy: a systemic review. J Vasc Surg, 2006, 44: 661–672.
  • North American Symptomatic Carotid Endarterectomy Trial (NASCHT) steering Comittee. North American Symptomatic Carotid Endarterectomy Trial: methods, patient characteristics and progress. Stroke, 1991, 22: 711–720.
  • CAVATAS-investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the carotid and vertebral artery transluminal angioplasty study (CAVATAS): a randomized trial. Lancet, 2001, 357: 1729–1737.
  • Gasparis A., Ricotta L., Cuadra S. et al. High-risk carotid endarterectomy: fact or fiction ? J Vasc Surg, 2003, 37: 4046.
  • Mozes G., Sullivan T., Torres-Russoto D. et al. Carotid endarterectomy in “SAPPHIRE-eligible” high-risk patients: implications for selecting patients for carotid angioplasty and stenting. J Vasc Surg, 2004, 39: 958–965.
  • Lepore M., Sternbergh C., Salartash K., Tonnessen B., Money S. Influence of NASCET/AÇAS trial eligibility on outcome after carotid endarterectomy. J Vasc Surg, 2001, 34: 581586.
  • Paciaroni M., Eliasziw M., Kappelle L. et al. Medical complications associated with carotid endarterectomy. North-American Symptomatic Carotid Endarterctomy Trial (NASCET). Stroke, 1999, 30: 1759–63.
  • Bell P. Limitations to the value of the SAPPHIRE trial. Acta Chir Belg, 2006, 106: 141–143.
  • Dietrich E., Ndiaye M., Reid B. Stenting in the carotid artery. Initial experience in 110 patients. J Endovasc Surg, 1996, 3: 4262.
  • Jordan W., Voellinger D., Doblar D., Plyushcheva N., Fisher W., McDowell H. Microemboli detected by transcranial doppler monitoring in patients during carotid angioplasty versus carotid endarterectomy. Cardiovasc Surg, 1999, 7: 33–38.
  • Cremonesi A., Manetti R., Castriota F., Setacci F., Stacci C. Protected carotid stenting: clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke, 2003, 34: 1936–1940.
  • Powell R., Alessi Ch., Nolan B. et al. Comparison of embolization protection device-specific technical difficulties during carotid artery stenting. J Vasc Surg, 2006, 44: 56–61.
  • Gray W., Hopkins N., Yadav S. et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg, 2006, 44: 258–269.
  • Eskandari M. Cerebral embolic protection. Semin Vasc Surg, 2005, 18: 95–100.
  • Eckert B., Zeumer H. Carotid artery stenting with or without protection devices ? Strong opinions, poor evidence ! Stroke, 2003, 34: 1941–1943.
  • Hammer f., Lacroix V., Duprez T., Grandin C., Verhelst R., Peeters A., Çosnard G. Cerebral microembolization after protected carotid artery stenting in surgical high risk patients: results of a 2-year prospective study. J Vasc Surg, 2005, 42: 847–853.
  • Vermeer S., Prins N., den Heijer T., Hofman A., Koudstaal P., Breteler M. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med, 2003, 348: 1215–1222.
  • Cantelmo N., Babikian V., Samazaweera R., Gordon J., Pochay V., Winter M. Cerebral microembolisation and ischemic changes associated with carotid endarterectomy. J Vasc Surg, 1998, 27: 1024–1031.
  • Mas J. L., Chatellier G., Beyssen B., Branchereau A., Moulin Th., Becquemin J. P. et al. for the EVA-3S Investigators. Endarterectomy versus Stenting in patients with symptomatic severe carotid stenosis. N Engl J Med, 2006, 355: 1660–71.
  • Bonneux L., Cleemput I., Ramaekers D. (KCE). PCAS: protected carotid artery stenting: a short medical technology assessment. Acta Chir Belg, 2005, 105: 436–441.
  • Hobson R. Carotid stenting: should it replace endarteretomy in higher-risk patients ? Seminars Vasc Surg, 2006, 19: 83–86.
  • North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med, 1991, 325: 445–453.
  • European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results for the MRC European Carotid Surgery Trial (ECST). Lancet, 1998, 351: 1379–87.
  • Rothwell P., Eliasziw M., Gutnickov S. et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet, 2003, 361: 107–116.
  • Mayberg M., Wilson E., Yatsu F. et al. for the Veterans Affairs Co-operative Studies Programme 309 Trialist Group. Carotid endarterectomy and ischaemia in symptomatic carotid stenosis. JAMA, 1991, 266: 3289–94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.